Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance associated mutations in breastfeeding women on antiretroviral therapy

Methods: The prevalence of mutations associated with antiretroviral drug resistance in protease (PR) and reverse transcriptase (RT) regions among antiretroviral treatment-naïve

To describe the frequency and characteristics of HIV drug resistance mutations (HIVDRM) in pregnant women with virological failure at delivery, despite pMTCT or antiretroviral ther-

Initiation of antiretroviral therapy or antiretroviral prophylaxis in pregnant women living with HIV registered in five townships of Mandalay, Myanmar A cross sectional study

Our overall goal was to determine seroprevalences and factors associated with viral infections (HIV, HBV, HCV) among pregnant women attending antenatal clinics at the

Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1 Infected Women for Maternal Health and Interventions to Reduce Perinatal

19,25,26 We report the results of our study aimed at determining the prevalence and pattern of HIV TDR mutations and subtypes among HIV- infected ART-naive pregnant women

Number of resistance mutations to antiretroviral drugs found among 103 HIV-1- infected untreated and treated patients in Cuba, according to HIV subtype, 1999.. Untreated

To describe the frequency and characteristics of HIV drug resistance mutations (HIVDRM) in pregnant women with virological failure at delivery, despite pMTCT or antiretroviral ther-